ArticleObesity surgery2026
Feasibility and Outcomes of a Uniform Drain-Free Strategy for Primary and Revisional Metabolic Bariatric Surgery under an ERAS Protocol.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Longitudinal Changes in Serum Procalcitonin After Bariatric Surgery and Their Associations with Anthropometric, Metabolic, and Inflammatory Parameters.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
introductionRoutine prophylactic drainage in metabolic bariatric surgery remains controversial, with limited evidence of clinical benefit, even in higher-risk procedures. Real-world data on a uniform drain-free strategy within enhanced recovery after surgery (ERAS) pathways are scarce. We assessed the feasibility of a uniform drain-free approach in primary and revisional metabolic bariatric surgery and its short-term outcomes.
methodsWe retrospectively reviewed 1,122 consecutive laparoscopic metabolic bariatric procedures performed by a single high-volume surgeon (2018–2024). No patients, including those undergoing revisional surgery, received prophylactic abdominal drains. Postoperative care followed a standardized ERAS protocol incorporating structured bedside assessment, serial biomarker monitoring, and criteria-driven imaging. Outcomes included major complications, transfusion, reoperation, postoperative length of stay (LOS), and 30-day readmission.
resultsThe cohort was 51.2% female, with a median age of 38 years and median body mass index of 37.8 kg/m². Overall 30-day morbidity was 3.2%, with most major events diagnosed after the typical drain-removal window and often beyond postoperative day 1. Anastomotic leakage occurred in five patients (0.4%; median 43 h) and was surgically repaired without ICU admission or residual abscess. Overt gastrointestinal bleeding occurred in 13 patients (1.2%); eight required readmission and six transfusion, all managed without hemodynamic instability, endoscopy, ICU admission, or reoperation. More than 92% of patients were discharged on postoperative day 1. Outcomes remained favorable in higher-risk and revisional procedures.
conclusionsA uniform drain-free strategy is feasible in primary and revisional metabolic bariatric surgery within a standardized ERAS pathway, with low short-term morbidity and efficient early recovery.
Indexed as
Identifiers
41973162What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.